CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 130.78 Million USD | 86.69% |
| 2022 | 70.05 Million USD | 85.1% |
| 2021 | 37.84 Million USD | 240.33% |
| 2020 | -26.97 Million USD | -1782.47% |
| 2019 | 1.6 Million USD | -97.75% |
| 2018 | 71.3 Million USD | 51.92% |
| 2017 | 46.93 Million USD | 24.58% |
| 2016 | 37.67 Million USD | -26.38% |
| 2015 | 51.17 Million USD | -3.05% |
| 2014 | 52.78 Million USD | -6.59% |
| 2013 | 56.5 Million USD | -13.34% |
| 2012 | 65.21 Million USD | 688.13% |
| 2011 | 8.27 Million USD | -85.51% |
| 2010 | 57.09 Million USD | 101.96% |
| 2009 | 28.26 Million USD | -62.44% |
| 2008 | 75.25 Million USD | -7.08% |
| 2007 | 80.99 Million USD | 1859.53% |
| 2006 | -4.6 Million USD | -107.22% |
| 2005 | 63.74 Million USD | 0.93% |
| 2004 | 63.16 Million USD | -21.0% |
| 2003 | 79.95 Million USD | 0.76% |
| 2002 | 79.34 Million USD | 15.07% |
| 2001 | 68.95 Million USD | 6.97% |
| 2000 | 64.46 Million USD | -13.82% |
| 1999 | 74.8 Million USD | 22.22% |
| 1998 | 61.2 Million USD | 137.21% |
| 1997 | 25.8 Million USD | 0.78% |
| 1996 | 25.6 Million USD | 36.17% |
| 1995 | 18.8 Million USD | 111.24% |
| 1994 | 8.9 Million USD | 568.42% |
| 1993 | -1.9 Million USD | -132.76% |
| 1992 | 5.8 Million USD | -4.92% |
| 1991 | 6.1 Million USD | 38.64% |
| 1990 | 4.4 Million USD | 1366.67% |
| 1989 | 300 Thousand USD | -72.73% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 42.28 Million USD | -1.59% |
| 2024 Q3 | 65.7 Million USD | 76.57% |
| 2024 Q2 | 37.21 Million USD | -12.0% |
| 2023 Q3 | 30.3 Million USD | 10.51% |
| 2023 Q4 | 42.97 Million USD | 41.82% |
| 2023 FY | 130.78 Million USD | 86.69% |
| 2023 Q2 | 27.41 Million USD | 623.74% |
| 2023 Q1 | -5.23 Million USD | -378.08% |
| 2022 Q3 | 6.62 Million USD | -72.93% |
| 2022 Q4 | -1.09 Million USD | -116.54% |
| 2022 Q1 | 5.61 Million USD | -84.92% |
| 2022 FY | 70.05 Million USD | 85.1% |
| 2022 Q2 | 24.45 Million USD | 335.74% |
| 2021 Q2 | 25.7 Million USD | 28.01% |
| 2021 Q1 | 20.08 Million USD | -18.7% |
| 2021 Q3 | 26.71 Million USD | 3.91% |
| 2021 Q4 | 37.21 Million USD | 39.33% |
| 2021 FY | 37.84 Million USD | 240.33% |
| 2020 Q4 | 24.7 Million USD | -15.93% |
| 2020 Q3 | 29.38 Million USD | 238.29% |
| 2020 Q2 | -21.24 Million USD | -261.3% |
| 2020 Q1 | 13.17 Million USD | -52.75% |
| 2020 FY | -26.97 Million USD | -1782.47% |
| 2019 Q1 | 11.63 Million USD | -54.93% |
| 2019 FY | 1.6 Million USD | -97.75% |
| 2019 Q2 | 18.65 Million USD | 60.33% |
| 2019 Q3 | 20.93 Million USD | 12.23% |
| 2019 Q4 | 27.87 Million USD | 33.14% |
| 2018 FY | 71.3 Million USD | 51.92% |
| 2018 Q2 | 16.68 Million USD | -3.45% |
| 2018 Q1 | 17.27 Million USD | -25.45% |
| 2018 Q4 | 25.82 Million USD | 124.11% |
| 2018 Q3 | 11.52 Million USD | -30.93% |
| 2017 Q3 | 13.47 Million USD | 5.37% |
| 2017 Q1 | -2.49 Million USD | -119.78% |
| 2017 FY | 46.93 Million USD | 24.58% |
| 2017 Q4 | 23.17 Million USD | 72.05% |
| 2017 Q2 | 12.78 Million USD | 612.55% |
| 2016 FY | 37.67 Million USD | -26.38% |
| 2016 Q4 | 12.6 Million USD | -8.96% |
| 2016 Q1 | 3.53 Million USD | -72.71% |
| 2016 Q3 | 13.84 Million USD | 80.21% |
| 2016 Q2 | 7.68 Million USD | 117.12% |
| 2015 FY | 51.17 Million USD | -3.05% |
| 2015 Q3 | 14.83 Million USD | 19.51% |
| 2015 Q4 | 12.96 Million USD | -12.61% |
| 2015 Q2 | 12.41 Million USD | 13.35% |
| 2015 Q1 | 10.95 Million USD | -35.9% |
| 2014 Q1 | 17.3 Million USD | 6.96% |
| 2014 FY | 52.78 Million USD | -6.59% |
| 2014 Q3 | 2.44 Million USD | -84.64% |
| 2014 Q2 | 15.94 Million USD | -7.9% |
| 2014 Q4 | 17.08 Million USD | 597.8% |
| 2013 Q1 | 15.87 Million USD | -6.73% |
| 2013 FY | 56.5 Million USD | -13.34% |
| 2013 Q4 | 16.18 Million USD | 83.77% |
| 2013 Q3 | 8.8 Million USD | -43.75% |
| 2013 Q2 | 15.65 Million USD | -1.37% |
| 2012 FY | 65.21 Million USD | 688.13% |
| 2012 Q3 | 14.11 Million USD | -17.26% |
| 2012 Q2 | 17.05 Million USD | 0.21% |
| 2012 Q1 | 17.02 Million USD | 140.89% |
| 2012 Q4 | 17.01 Million USD | 20.56% |
| 2011 Q4 | -41.62 Million USD | -361.15% |
| 2011 FY | 8.27 Million USD | -85.51% |
| 2011 Q2 | 16.69 Million USD | -3.27% |
| 2011 Q3 | 15.94 Million USD | -4.54% |
| 2011 Q1 | 17.26 Million USD | 27.38% |
| 2010 Q2 | 14.77 Million USD | 8.97% |
| 2010 Q3 | 15.2 Million USD | 2.87% |
| 2010 Q4 | 13.55 Million USD | -10.85% |
| 2010 FY | 57.09 Million USD | 101.96% |
| 2010 Q1 | 13.56 Million USD | 24.57% |
| 2009 Q2 | 5.03 Million USD | -31.46% |
| 2009 FY | 28.26 Million USD | -62.44% |
| 2009 Q4 | 10.88 Million USD | 117.63% |
| 2009 Q3 | 5 Million USD | -0.66% |
| 2009 Q1 | 7.34 Million USD | -47.62% |
| 2008 Q4 | 14.02 Million USD | -20.06% |
| 2008 Q3 | 17.54 Million USD | -22.55% |
| 2008 Q2 | 22.65 Million USD | 7.66% |
| 2008 Q1 | 21.04 Million USD | -4.13% |
| 2008 FY | 75.25 Million USD | -7.08% |
| 2007 Q3 | 16.91 Million USD | -10.44% |
| 2007 Q2 | 18.88 Million USD | -18.73% |
| 2007 FY | 80.99 Million USD | 1859.53% |
| 2007 Q4 | 21.94 Million USD | 29.74% |
| 2007 Q1 | 23.24 Million USD | 165.49% |
| 2006 Q4 | -35.48 Million USD | -486.4% |
| 2006 FY | -4.6 Million USD | -107.22% |
| 2006 Q3 | 9.18 Million USD | -13.1% |
| 2006 Q2 | 10.56 Million USD | -5.05% |
| 2006 Q1 | 11.13 Million USD | 42.29% |
| 2005 FY | 63.74 Million USD | 0.93% |
| 2005 Q4 | 7.82 Million USD | -51.46% |
| 2005 Q3 | 16.11 Million USD | -17.83% |
| 2005 Q2 | 19.61 Million USD | -2.87% |
| 2005 Q1 | 20.19 Million USD | 40.53% |
| 2004 Q1 | 21.82 Million USD | -28.16% |
| 2004 Q4 | 14.37 Million USD | 161.51% |
| 2004 Q2 | 21.46 Million USD | -1.64% |
| 2004 Q3 | 5.49 Million USD | -74.4% |
| 2004 FY | 63.16 Million USD | -21.0% |
| 2003 Q2 | 10.17 Million USD | -64.04% |
| 2003 Q4 | 30.38 Million USD | 59.95% |
| 2003 Q1 | 28.3 Million USD | 56.24% |
| 2003 FY | 79.95 Million USD | 0.76% |
| 2003 Q3 | 18.99 Million USD | 86.63% |
| 2002 FY | 79.34 Million USD | 15.07% |
| 2002 Q1 | 20.8 Million USD | 9.67% |
| 2002 Q2 | 20.33 Million USD | -2.26% |
| 2002 Q3 | 20.08 Million USD | -1.23% |
| 2002 Q4 | 18.11 Million USD | -9.83% |
| 2001 Q1 | 17.71 Million USD | 0.33% |
| 2001 FY | 68.95 Million USD | 6.97% |
| 2001 Q4 | 18.97 Million USD | 22.68% |
| 2001 Q3 | 15.46 Million USD | -7.98% |
| 2001 Q2 | 16.8 Million USD | -5.09% |
| 2000 FY | 64.46 Million USD | -13.82% |
| 2000 Q1 | 19.98 Million USD | -7.92% |
| 2000 Q2 | 13.73 Million USD | -31.28% |
| 2000 Q3 | 13.09 Million USD | -4.62% |
| 2000 Q4 | 17.65 Million USD | 34.77% |
| 1999 Q1 | 17.7 Million USD | -1.67% |
| 1999 Q2 | 18.3 Million USD | 3.39% |
| 1999 Q4 | 21.7 Million USD | 27.65% |
| 1999 Q3 | 17 Million USD | -7.1% |
| 1999 FY | 74.8 Million USD | 22.22% |
| 1998 Q3 | 17.1 Million USD | 16.33% |
| 1998 FY | 61.2 Million USD | 137.21% |
| 1998 Q2 | 14.7 Million USD | 30.09% |
| 1998 Q4 | 18 Million USD | 5.26% |
| 1998 Q1 | 11.3 Million USD | 44.87% |
| 1997 Q1 | 5.9 Million USD | -16.9% |
| 1997 Q3 | 6.9 Million USD | 38.0% |
| 1997 Q2 | 5 Million USD | -15.25% |
| 1997 Q4 | 7.8 Million USD | 13.04% |
| 1997 FY | 25.8 Million USD | 0.78% |
| 1996 Q3 | 6.1 Million USD | -6.15% |
| 1996 Q1 | 5.8 Million USD | 1.75% |
| 1996 Q4 | 7.1 Million USD | 16.39% |
| 1996 FY | 25.6 Million USD | 36.17% |
| 1996 Q2 | 6.5 Million USD | 12.07% |
| 1995 Q1 | 3.1 Million USD | 14.81% |
| 1995 Q4 | 5.7 Million USD | 9.62% |
| 1995 Q3 | 5.2 Million USD | 6.12% |
| 1995 FY | 18.8 Million USD | 111.24% |
| 1995 Q2 | 4.9 Million USD | 58.06% |
| 1994 Q1 | 1.9 Million USD | 154.29% |
| 1994 FY | 8.9 Million USD | 568.42% |
| 1994 Q4 | 2.7 Million USD | 17.39% |
| 1994 Q3 | 2.3 Million USD | 15.0% |
| 1994 Q2 | 2 Million USD | 5.26% |
| 1993 Q3 | 800 Thousand USD | 166.67% |
| 1993 Q4 | -3.5 Million USD | -537.5% |
| 1993 FY | -1.9 Million USD | -132.76% |
| 1993 Q1 | 700 Thousand USD | -36.36% |
| 1993 Q2 | 300 Thousand USD | -57.14% |
| 1992 Q2 | 1.9 Million USD | 0.0% |
| 1992 Q1 | 1.9 Million USD | 11.76% |
| 1992 FY | 5.8 Million USD | -4.92% |
| 1992 Q3 | 1 Million USD | -47.37% |
| 1992 Q4 | 1.1 Million USD | 10.0% |
| 1991 FY | 6.1 Million USD | 38.64% |
| 1991 Q1 | 1.4 Million USD | 40.0% |
| 1991 Q4 | 1.7 Million USD | 6.25% |
| 1991 Q3 | 1.6 Million USD | 6.67% |
| 1991 Q2 | 1.5 Million USD | 7.14% |
| 1990 Q2 | 1.2 Million USD | 9.09% |
| 1990 FY | 4.4 Million USD | 1366.67% |
| 1990 Q4 | 1 Million USD | -16.67% |
| 1990 Q3 | 1.2 Million USD | 0.0% |
| 1990 Q1 | 1.1 Million USD | 0.0% |
| 1989 Q2 | 4.4 Million USD | 12.82% |
| 1989 Q4 | - USD | 100.0% |
| 1989 FY | 300 Thousand USD | -72.73% |
| 1989 Q1 | 3.9 Million USD | 141.05% |
| 1989 Q3 | -200 Thousand USD | -104.55% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 97.981% |
| Allurion Technologies Inc. | -78.07 Million USD | 267.507% |
| Artivion, Inc. | 5.74 Million USD | -2177.708% |
| Avanos Medical, Inc. | 4.2 Million USD | -3013.952% |
| Butterfly Network, Inc. | -145.61 Million USD | 189.819% |
| Butterfly Network, Inc. | -145.61 Million USD | 189.819% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 65.923% |
| Boston Scientific Corporation | 2.34 Billion USD | 94.418% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 961.454% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 91.475% |
| Paragon 28, Inc. | -37.3 Million USD | 450.548% |
| Glaukos Corporation | -128.7 Million USD | 201.621% |
| Globus Medical, Inc. | 133.14 Million USD | 1.77% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 424.765% |
| Integer Holdings Corporation | 167.33 Million USD | 21.839% |
| Medtronic plc | 5.14 Billion USD | 97.458% |
| Nevro Corp. | -99.3 Million USD | 231.697% |
| Owlet, Inc. | -28.63 Million USD | 556.783% |
| Penumbra, Inc. | 73.55 Million USD | -77.817% |
| Vicarious Surgical Inc. | -80.66 Million USD | 262.133% |
| Smith & Nephew plc | 425 Million USD | 69.227% |
| Sonendo, Inc. | -57.74 Million USD | 326.497% |
| STERIS plc | 836.11 Million USD | 84.358% |
| Stryker Corporation | 3.88 Billion USD | 96.636% |
| Vapotherm, Inc. | -39.08 Million USD | 434.662% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 89.764% |